BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang T, Yang Z, Kusumanchi P, Han S, Liangpunsakul S. Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases. Front Med (Lausanne) 2020;7:7. [PMID: 32083086 DOI: 10.3389/fmed.2020.00007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Zaiou M. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease. World J Gastroenterol 2022; 28(35): 5111-5128 [DOI: 10.3748/wjg.v28.i35.5111] [Reference Citation Analysis]
2 Raskurazhev AA, Kuznetsova PI, Shabalina AA, Tanashyan MM. MicroRNA and Hemostasis Profile of Carotid Atherosclerosis. Int J Mol Sci 2022;23:10974. [PMID: 36142883 DOI: 10.3390/ijms231810974] [Reference Citation Analysis]
3 Akhtarkhavari T, Bahrami AR, M Matin M. Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer. Eur J Pharmacol 2022;:175233. [PMID: 36038011 DOI: 10.1016/j.ejphar.2022.175233] [Reference Citation Analysis]
4 Liu S, Wu W, Liao J, Tang F, Gao G, Peng J, Fu X, Zhan Y, Chen Z, Xu W, Zhao S. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy. Front Endocrinol 2022;13:895010. [DOI: 10.3389/fendo.2022.895010] [Reference Citation Analysis]
5 Ahmed N, Ahmed N, Pezacki JP. miR-383 Regulates Hepatic Lipid Homeostasis and Response to Dengue Virus Infection. ACS Infect Dis 2022;8:928-41. [PMID: 35254825 DOI: 10.1021/acsinfecdis.1c00470] [Reference Citation Analysis]
6 Khan AA, Gupta V, Mahapatra NR. Key regulatory miRNAs in lipid homeostasis: implications for cardiometabolic diseases and development of novel therapeutics. Drug Discov Today 2022:S1359-6446(22)00190-8. [PMID: 35550438 DOI: 10.1016/j.drudis.2022.05.003] [Reference Citation Analysis]
7 Czaja AJ. Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis. Expert Rev Clin Immunol 2022. [PMID: 35510750 DOI: 10.1080/1744666X.2022.2074839] [Reference Citation Analysis]
8 Salman M, Kamel MA, El-Nabi SEH, Ismail AHA, Ullah S, Al-Ghamdi A, Hathout HMR, El-Garawani IM. The regulation of HBP1, SIRT1, and SREBP-1c genes and the related microRNAs in non-alcoholic fatty liver rats: The association with the folic acid anti-steatosis. PLoS One 2022;17:e0265455. [PMID: 35417465 DOI: 10.1371/journal.pone.0265455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 El-Mahdy HA, Sallam AM, Ismail A, Elkhawaga SY, Elrebehy MA, Doghish AS. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathol Res Pract 2022;233:153886. [PMID: 35405621 DOI: 10.1016/j.prp.2022.153886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xie J, Wu W, Zheng L, Lin X, Tai Y, Wang Y, Wang L. Roles of MicroRNA-21 in Skin Wound Healing: A Comprehensive Review. Front Pharmacol 2022;13:828627. [PMID: 35295323 DOI: 10.3389/fphar.2022.828627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yang Z, Han S, Zhang T, Kusumanchi P, Huda N, Tyler K, Chandler K, Skill NJ, Tu W, Shan M, Jiang Y, Maiers JL, Perez K, Ma J, Liangpunsakul S. Transcriptomic Analysis Reveals the Messenger RNAs Responsible for the Progression of Alcoholic Cirrhosis. Hepatol Commun 2022. [PMID: 35134262 DOI: 10.1002/hep4.1903] [Reference Citation Analysis]
12 Almohawes ZN, El-kott A, Morsy K, Shati AA, El-kenawy AE, Khalifa HS, Elsaid FG, Abd-lateif AM, Abu-zaiton A, Ebealy ER, Abdel-daim MM, Ghanem RA, Abd-ella EM. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats. Archives of Physiology and Biochemistry. [DOI: 10.1080/13813455.2021.2024578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Djebbi K, Shi B, Weng T, Bahri M, Elaguech MA, Liu J, Tlili C, Wang D. Highly Sensitive Fluorescence Assay for miRNA Detection: Investigation of the DNA Spacer Effect on the DSN Enzyme Activity toward Magnetic-Bead-Tethered Probes. ACS Omega 2022;7:2224-33. [PMID: 35071911 DOI: 10.1021/acsomega.1c05775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kaur N, Goyal G, Garg R, Tapasvi C, Chawla S, Kaur R. Potential role of noninvasive biomarkers during liver fibrosis. World J Hepatol 2021; 13(12): 1919-1935 [DOI: 10.4254/wjh.v13.i12.1919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Naudhani M, Thakur K, Ni ZJ, Zhang JG, Wei ZJ. Formononetin reshapes the gut microbiota, prevents progression of obesity and improves host metabolism. Food Funct 2021;12:12303-24. [PMID: 34821251 DOI: 10.1039/d1fo02942h] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Babuta M, Szabo G. Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases. J Leukoc Biol 2021. [PMID: 34755380 DOI: 10.1002/JLB.3MIR0321-156R] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
17 Zhang L, Gao J, Zhou D, Wang X, Li J, Wang J, Chen H, Xie X, Chen T. Profiles of messenger RNAs and MicroRNAs in hypoxia-induced hepatic stellate cells. Ann Transl Med 2021;9:1451. [PMID: 34734003 DOI: 10.21037/atm-21-4215] [Reference Citation Analysis]
18 Yang Z, Zhang T, Kusumanchi P, Tang Q, Sun Z, Radaeva S, Peiffer B, Shah VH, Kamath P, Gores GJ, Sanyal A, Chalasani N, Jiang Y, Huda N, Ma J, Liangpunsakul S. Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis. Hepatology 2021;74:2436-51. [PMID: 34096637 DOI: 10.1002/hep.31994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
19 Zhang J, Li D, Zhang R, Peng R, Li J. Delivery of microRNA-21-sponge and pre-microRNA-122 by MS2 virus-like particles to therapeutically target hepatocellular carcinoma cells. Exp Biol Med (Maywood) 2021;246:2463-72. [PMID: 34644206 DOI: 10.1177/15353702211035689] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clément S, Maeder C, Dolicka D, Fournier M, Vinet L, Montet X, Dufour JF, Humar B, Negro F, Sempoux C, Foti M. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel) 2021;13:4983. [PMID: 34638467 DOI: 10.3390/cancers13194983] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
21 Zhu B, Chan SL, Li J, Li K, Wu H, Cui K, Chen H. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment. Front Cardiovasc Med 2021;8:742382. [PMID: 34557535 DOI: 10.3389/fcvm.2021.742382] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Petkevich AA, Abramov AA, Pospelov VI, Malinina NA, Kuhareva EI, Mazurchik NV, Tarasova OI. Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer. Oncotarget 2021;12:1697-706. [PMID: 34434498 DOI: 10.18632/oncotarget.28036] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Otsuka K, Ochiya T. Possible connection between diet and microRNA in cancer scenario. Seminars in Cancer Biology 2021;73:4-18. [DOI: 10.1016/j.semcancer.2020.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kim HG, Cho JH, Kim J, Kim SJ. The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis. Front Physiol 2021;12:691738. [PMID: 34335299 DOI: 10.3389/fphys.2021.691738] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Talib WH, Mahmod AI, Kamal A, Rashid HM, Alashqar AMD, Khater S, Jamal D, Waly M. Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities. Curr Issues Mol Biol 2021;43:558-89. [PMID: 34287243 DOI: 10.3390/cimb43020042] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
26 Ezhilarasan D. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. Toxicology 2021;458:152840. [PMID: 34175381 DOI: 10.1016/j.tox.2021.152840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ghaderi F, Jokar N, Gholamrezanezhad A, Assadi M, Ahmadzadehfar H. Toward radiotheranostics in cancer stem cells: a promising initial step for tumour eradication. Clin Transl Imaging 2021;9:561-78. [DOI: 10.1007/s40336-021-00444-x] [Reference Citation Analysis]
28 Escutia-Gutiérrez R, Rodríguez-Sanabria JS, Monraz-Méndez CA, García-Bañuelos J, Santos-García A, Sandoval-Rodríguez A, Armendáriz-Borunda J. Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH. Sci Rep 2021;11:11709. [PMID: 34083664 DOI: 10.1038/s41598-021-91187-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Nguyen HT, Kacimi SEO, Nguyen TL, Suman KH, Lemus-Martin R, Saleem H, Do DN. MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology (Basel) 2021;10:417. [PMID: 34066762 DOI: 10.3390/biology10050417] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
30 Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
31 Fang Z, Dou G, Wang L. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Int J Biol Sci 2021;17:1851-63. [PMID: 33994867 DOI: 10.7150/ijbs.59588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
32 Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 2021;70:784-95. [PMID: 33127832 DOI: 10.1136/gutjnl-2020-322526] [Cited by in Crossref: 79] [Cited by in F6Publishing: 92] [Article Influence: 79.0] [Reference Citation Analysis]
33 Melnik BC. Dairy consumption and hepatocellular carcinoma risk. Ann Transl Med 2021;9:736. [PMID: 33987434 DOI: 10.21037/atm-2020-ubih-06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Alshammari GM, Al-Qahtani WH, AlFaris NA, Alzahrani NS, Alkhateeb MA, Yahya MA. Quercetin prevents cadmium chloride-induced hepatic steatosis and fibrosis by downregulating the transcription of miR-21. Biofactors 2021;47:489-505. [PMID: 33733575 DOI: 10.1002/biof.1724] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
35 Shakeri A, Ghanbari M, Tasbandi A, Sahebkar A. Regulation of microRNA-21 expression by natural products in cancer. Phytother Res 2021;35:3732-46. [PMID: 33724576 DOI: 10.1002/ptr.7069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Lai CY, Yeh KY, Lin CY, Hsieh YW, Lai HH, Chen JR, Hsu CC, Her GM. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers (Basel) 2021;13:940. [PMID: 33668153 DOI: 10.3390/cancers13050940] [Cited by in Crossref: 7] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
37 Zhao W, Ning L, Wang L, Ouyang T, Qi L, Yang R, Wu Y. miR-21 inhibition reverses doxorubicin-resistance and inhibits PC3 human prostate cancer cells proliferation. Andrologia 2021;53:e14016. [PMID: 33598946 DOI: 10.1111/and.14016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Mohr R, Özdirik B, Lambrecht J, Demir M, Eschrich J, Geisler L, Hellberg T, Loosen SH, Luedde T, Tacke F, Hammerich L, Roderburg C. From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis. Int J Mol Sci 2021;22:1492. [PMID: 33540837 DOI: 10.3390/ijms22031492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
40 Wu J, Nagy LE, Liangpunsakul S, Wang L. Non-coding RNA crosstalk with nuclear receptors in liver disease. Biochim Biophys Acta Mol Basis Dis 2021;1867:166083. [PMID: 33497819 DOI: 10.1016/j.bbadis.2021.166083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Oura K, Morishita A, Masaki T. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int J Mol Sci 2020;21:E8362. [PMID: 33171811 DOI: 10.3390/ijms21218362] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
42 Zhang J, Li D, Zhang R, Gao P, Peng R, Li J. The miR-21 potential of serving as a biomarker for liver diseases in clinical practice. Biochem Soc Trans 2020;48:2295-305. [PMID: 33119045 DOI: 10.1042/BST20200653] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Gao W, Chen X, Chi W, Xue M. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression. Int J Mol Med 2020;46:1743-54. [PMID: 33000222 DOI: 10.3892/ijmm.2020.4722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
44 Ezhilarasan D. MicroRNA interplay between hepatic stellate cell quiescence and activation. Eur J Pharmacol 2020;885:173507. [PMID: 32858048 DOI: 10.1016/j.ejphar.2020.173507] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
45 Han S, Zhang T, Kusumanchi P, Huda N, Jiang Y, Liangpunsakul S, Yang Z. Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications. J Investig Med 2020;68:1208-16. [PMID: 32843369 DOI: 10.1136/jim-2020-001420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
46 Lendvai G, Szekerczés T, Kontsek E, Selvam A, Szakos A, Schaff Z, Björnstedt M, Kiss A. The Effect of Methylselenocysteine and Sodium Selenite Treatment on microRNA Expression in Liver Cancer Cell Lines. Pathol Oncol Res 2020;26:2669-81. [PMID: 32656599 DOI: 10.1007/s12253-020-00870-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]